Document Detail


Sleep disturbances, daytime sleepiness, and quality of life in adults with growth hormone deficiency.
MedLine Citation:
PMID:  20332249     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: Low energy and fatigue are frequent complaints in subjects with GH deficiency (GHD). Because interrelations between sleep and GH regulation are well documented, these complaints could partly reflect alterations of sleep quality.
OBJECTIVE: The objective of the study was to determine objective and subjective sleep quality and daytime sleepiness in adult GHD patients.
SUBJECTS: Thirty patients, aged 19-74 yr, with untreated GHD (primary pituitary defects confirmed or likely in 26 patients, hypothalamic origin in four patients), and 30 healthy controls individually matched for gender, age, and body mass index participated in the study. Patients with associated pituitary deficiencies (n = 28) were on hormonal replacement therapy.
METHODS: Polygraphic sleep recordings, assessment of Pittsburgh Sleep Quality Index, and Quality of Life Assessment for GHD in Adults were measured.
RESULTS: Irrespective of etiology, GHD patients had a Pittsburgh Sleep Quality Index score above the clinical cutoff for poor sleep and lower Quality of Life Assessment for GHD in Adults scores than controls, with tiredness being the most affected domain. Patients with pituitary GHD spent more time in slow-wave sleep (SWS) and had a higher intensity of SWS than their controls. Among these patients, older individuals obtained less total sleep than controls, and their late sleep was more fragmented. Contrasting with pituitary GHD, the four patients with hypothalamic GHD had lower intensity of SWS than their controls.
CONCLUSIONS: GHD is associated with sleep disorders that may be caused by specific hormonal alterations as well as with poor subjective sleep quality and daytime sleepiness. Disturbed sleep is likely to be partly responsible for increased tiredness, a major component of quality of life in GHD.
Authors:
Georges Copinschi; Arlet Nedeltcheva; Rachel Leproult; Lisa L Morselli; Karine Spiegel; Enio Martino; Jean-Jacques Legros; Roy E Weiss; Jean Mockel; Eve Van Cauter
Related Documents :
15831839 - The effect of infective exacerbations on sleep and neurobehavioral function in cystic f...
21185219 - Head eye co-ordination and gaze stability in subjects with persistent whiplash associat...
2878389 - Effects of temazepam on sleep quality and subsequent mental efficiency under normal sle...
19694879 - Sleep quality and sleep disturbing factors of inpatients in a chinese general hospital.
21109749 - Assessment of sleep impairment in persistent allergic rhinitis patients using polysomno...
12615559 - Does melatonin improve sleep in older people? a randomised crossover trial.
23628349 - Cataract extraction outcomes and the prevalence of zonular insufficiency in retinitis p...
12504689 - Photodynamic therapy using verteporfin for choroidal neovascularization in angioid stre...
15831839 - The effect of infective exacerbations on sleep and neurobehavioral function in cystic f...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-03-23
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  95     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-06     Completed Date:  2010-05-28     Revised Date:  2013-03-07    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2195-202     Citation Subset:  AIM; IM    
Affiliation:
Laboratoire de Physiologie, Université Libre de Bruxelles CP 604, 808 Route de Lennik, B-1070 Brussels, Belgium. gcop@ulb.ac.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenocorticotropic Hormone / blood
Adult
Fatigue / physiopathology*
Female
Follicle Stimulating Hormone / blood
Homeostasis
Hormone Replacement Therapy
Human Growth Hormone / deficiency*,  therapeutic use
Humans
Luteinizing Hormone / blood
Male
Middle Aged
Quality of Life*
Reference Values
Sleep Disorders / drug therapy,  epidemiology*
Sleep Stages / physiology
Sleep, REM / physiology
Thyrotropin / blood
Grant Support
ID/Acronym/Agency:
M01 RR-00055/RR/NCRR NIH HHS; P01 AG-11412/AG/NIA NIH HHS; T32 HL-07909/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
12629-01-5/Human Growth Hormone; 9002-60-2/Adrenocorticotropic Hormone; 9002-67-9/Luteinizing Hormone; 9002-68-0/Follicle Stimulating Hormone; 9002-71-5/Thyrotropin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neu...
Next Document:  Sleep-Disordered Breathing Is Increased in Obese Adolescents with Craniopharyngioma Compared with Ob...